Review decisions
Showing 700 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00988
Product Type: Drug
Control Number: 255495
DIN(s): 02530163, 02530171
Manufacturer: Eli Lilly Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-08-05
Decision / Authorization Date: 2022-08-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00991
Product Type: Drug
Control Number: 260951
DIN(s): 02530198
Manufacturer: Advanced Accelerator Applications USA, Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-01-28
Decision / Authorization Date: 2022-08-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00999
Product Type: Drug
Control Number: 259448
DIN(s): 02530031
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-11-10
Decision / Authorization Date: 2022-08-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00983
Product Type: Drug
Control Number: 264621
DIN(s): 02522454
Manufacturer: Pfizer Canada ULC., on behalf of BioNTech Manufacturing GmbH
Submission Type: Supplement to a New Drug Submission (COVID-19)
Date Filed / Submission Date: 2022-05-27
Decision / Authorization Date: 2022-08-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1685635290781
Product Type: Drug
Control Number: 267120
DIN(s): 02536080, 02536099, 02536102, 02536110
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: New Drug Submission (New Active Substance) - Priority Review
Date Filed / Submission Date: 2022-08-19
Issued / Original Publication Date: 2023-05-31
Decision / Authorization Date: 2023-03-10
Updated Date: 2024-06-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00990
Product Type: Drug
Control Number: 261300
Manufacturer: Bristol-Myers Squibb Canada Co.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2022-02-08
Decision / Authorization Date: 2022-08-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01069
Product Type: Drug
Control Number: 256537
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-09-09
Decision / Authorization Date: 2022-08-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1712172719912
Product Type: Drug
Control Number: 267148
DIN(s): 02541742
Manufacturer: Sumitomo Pharma Switzerland GmbH
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-08-18
Issued / Original Publication Date: 2024-03-28
Decision / Authorization Date: 2023-09-22
Updated Date: 2025-01-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01042
Product Type: Drug
Control Number: 254548
DIN(s): 02532468
Manufacturer: Vifor Fresenius Medical Care Renal Pharma Ltd.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-09-10
Decision / Authorization Date: 2022-08-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00984
Product Type: Drug
Control Number: 257327
Manufacturer: BGP Pharma ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-10-06
Decision / Authorization Date: 2022-08-12